Abstract Information

INSTRUCTIONS FOR ABSTRACT SUBMISSION

NEW DEADLINE: May 8, 2017

(Late breaker deadline: July 10, 2017 - strict conditions to be complied with - read more)

ALL ABSTRACTS MUST BE SUBMITTED THROUGH THE ONLINE ABSTRACT SUBMISSION SYSTEM.

Submit your abstract here

In the online process you will first need to create a “Submitter Account”.

Following the creation of the submitter account you will receive an email with your personal access code.
The submission process requires to identify the abstract submitter and the main author (this may be the same person or two different persons).
The system will allow you to start drafting the abstract and to work on it including interruptions, and to save it as often as you wish as a draft before eventually submitting the final version.

General Conditions for Submission of Abstracts
Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2017 Congress and that financial resources to attend are available; 

Abstract presenters who would like to benefit from the early bird registration rate (deadline is April 3) are advised to submit their abstract before March 31 and send a short notice to This email address is being protected from spambots. You need JavaScript enabled to view it.. They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate

  1. Authors are requested to register within 10 days after having received their provisional notification of acceptance. Abstracts of authors not registered by May 20, 2017 will not be taken into consideration for the final program.
    Abstract presenters who would like to benefit from the early bird registration rate (deadline is April 3) are advised to submit their abstract before March 31 and send a short notice to This email address is being protected from spambots. You need JavaScript enabled to view it. . They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate.
    If the abstract presenter is registered with a group, please inform the Congress Secretariat at: This email address is being protected from spambots. You need JavaScript enabled to view it. and indicate the person who booked the group registration.
  2. Abstracts must be submitted and presented in ENGLISH
  3. Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;
  4. For proffered papers (for Oral Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;
  5. Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;
  6. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;
  7. The final decision of the Scientific Committee will be announced before May 15, 2017;
  8. Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)
  9. All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference). The main author and the presenter can be the same person. They may also be identical to or different from the submitter);
  10. The main author and the presenter must be identified (by ticking the corresponding boxes)
  11. For further information and assistance please contact the scientific secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it.

   
Abstract Editing Instructions  

  1. Abstracts must be submitted through the online submission system;
  2. Maximum length (body of abstract): 2700 characters;
  3. The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation. ;
  4. Please avoid complex mathematical formulae; the system allows to insert simple tables.
  5. Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned.
  6. All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract.
  7. Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
  8. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
  9. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
  10. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
  11. Drugs must be identified by their generic names


Abstract Topics   

For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form: 

  1. Viral and molecular biology
  2. Epidemiology and natural history
  3. Pathogenesis
  4. Immunology
  5. HPV prophylactic vaccines
  6. HPV therapeutic vaccines
  7. Immunotherapy - Immuno-oncology - New treatments
  8. HPV testing
  9. HPV screening
  10. Self-sampling
  11. Genotyping
  12. Molecular markers
  13. Screening methods
  14. Liquid based cytology
  15. Automation in cytology
  16. Methylation
  17. Microbiome
  18. Serology
  19. New technologies
  20. Diagnostic procedures / management
  21. Colposcopy
  22. Cervical neoplasia
  23. Vaginal neoplasia
  24. Vulvar diseases and neoplasia
  25. Anal neoplasia
  26. Oral HPV infection
  27. HPV and oropharynx / Head and neck cancer
  28. HPV and associated skin diseases
  29. Genital warts
  30. Sexually transmitted diseases and HIV infection
  31. Conventional therapies
  32. Economics and modelling
  33. Advocacy, acceptability and psychology
  34. Health education
  35. Low resource settings
  36. Public health

About EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

Newsletter